Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 16, 2016
DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury
Jee Eun Lee, Jung Eun Kim, Mi Hwa Lee, et al.
Genome Biology
|
October 9, 2013
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development
Yi-An Ko, Davoud Mohtat, Masako Suzuki, et al.
Kidney Research and Clinical Practice
|
April 11, 2017
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 10, 2018
Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78]
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney International
|
December 22, 2004
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Nan Hee Kim, Jeong Heon Oh, Ji A Seo, et al.
Plos One
|
May 3, 2013
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice
Jung Eun Kim, Mi Hwa Lee, Deok Hwa Nam, et al.
Kidney International
|
August 6, 2010
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
Young Sun Kang, Mi Hwa Lee, Hye Kyoung Song, et al.
The Korean Journal of Internal Medicine
|
November 28, 2017
Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease
Seon Ha Baek, Ran-Hui Cha, Shin Wook Kang, et al.
Plos One
|
June 2, 2016
Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study
Sung Woo Lee, Sejoong Kim, Ki Young Na, et al.
Kidney Research and Clinical Practice
|
February 4, 2024
Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 16, 2016
DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury
Jee Eun Lee, Jung Eun Kim, Mi Hwa Lee, et al.
Genome Biology
|
October 9, 2013
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development
Yi-An Ko, Davoud Mohtat, Masako Suzuki, et al.
Kidney Research and Clinical Practice
|
April 11, 2017
Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney Research and Clinical Practice
|
April 10, 2018
Erratum: Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: <i>post-hoc</i> analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pages 68-78]
Ran-Hui Cha, Shin Wook Kang, Cheol Whee Park, et al.
Kidney International
|
December 22, 2004
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
Nan Hee Kim, Jeong Heon Oh, Ji A Seo, et al.
Plos One
|
May 3, 2013
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice
Jung Eun Kim, Mi Hwa Lee, Deok Hwa Nam, et al.
Kidney International
|
August 6, 2010
CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice
Young Sun Kang, Mi Hwa Lee, Hye Kyoung Song, et al.
The Korean Journal of Internal Medicine
|
November 28, 2017
Circulating renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease
Seon Ha Baek, Ran-Hui Cha, Shin Wook Kang, et al.
Plos One
|
June 2, 2016
Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study
Sung Woo Lee, Sejoong Kim, Ki Young Na, et al.
Kidney Research and Clinical Practice
|
February 4, 2024
Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha, et al.
Page
of 10